Liu Shuzheng, Dai James Y, Yao Lena, Li Xiaohong, Reid Brian, Self Steve, Ma Jie, Chang Yuxi, Feng Shixian, Tapsoba Jean de Dieu, Sun Xin, Sun Xibin
Henan Office for Cancer Research and Control, Henan Cancer Hospital, Zhengzhou, Henan Province, China.
Vaccine and Infectious Diseases and Public Health Science Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
PLoS One. 2014 Oct 15;9(10):e110348. doi: 10.1371/journal.pone.0110348. eCollection 2014.
Incidence of esophageal adenocarcinoma (EAC) has increased sharply in Western Europe and United States over the past three decades. Nearly all cases of EAC in the west are thought to be associated with Barrett's esophagus (BE) at the time of diagnosis. Regions in the Henan province of China have one of world's highest incidences of esophageal cancer, yet recent temporal trends in the relative rates of EAC with respect to esophageal squamous-cell carcinoma (ESCC), as well as its association with Barrett's esophagus (BE), have not been reported. In this report, we present large-scale longitudinal clinical and histological data on 5401 esophageal cancers (EC) patients diagnosed during the recent 10-year period (2002-2011) at Henan Cancer Hospital, China. All 217 esophageal adenocarcinoma (EAC) patients from these 5401 EC patients were examined to better understand the relationship between Barrett's esophagus (BE) and EAC. We found that EAC was relatively rare and accounted for approximately 5% of all esophageal cancers each year during 2002-2011. There is no evidence of significant temporal trends in the rate of EAC relative to ESCC. Only 10 out of 217 (4.6%) EAC cases were detected to have any evidence of Barrett's esophagus. This result raises the possibility of a different etiological basis for EAC in China motivating more detailed epidemiological, clinical and molecular characterization of EAC in China in order to better understand the neoplastic development of EAC.
在过去三十年中,西欧和美国的食管腺癌(EAC)发病率急剧上升。在西方,几乎所有EAC病例在诊断时都被认为与巴雷特食管(BE)有关。中国河南省是世界上食管癌发病率最高的地区之一,但关于EAC相对于食管鳞状细胞癌(ESCC)的相对发病率的近期时间趋势及其与巴雷特食管(BE)的关联,尚未见报道。在本报告中,我们展示了中国河南省肿瘤医院在最近10年期间(2002 - 2011年)诊断的5401例食管癌(EC)患者的大规模纵向临床和组织学数据。对这5401例EC患者中的所有217例食管腺癌(EAC)患者进行了检查,以更好地了解巴雷特食管(BE)与EAC之间的关系。我们发现,EAC相对罕见,在2002 - 2011年期间每年约占所有食管癌的5%。没有证据表明EAC相对于ESCC的发病率有显著的时间趋势。在217例EAC病例中,只有10例(4.6%)被检测出有任何巴雷特食管的证据。这一结果增加了中国EAC病因基础不同的可能性,促使对中国EAC进行更详细的流行病学、临床和分子特征分析,以便更好地了解EAC的肿瘤发生发展。